EPO906 Therapy in Patients With Advanced Kidney Cancer

Clinical trial NCT00035243 · COMPLETED

Trial details

NCT number: NCT00035243
Sponsor: Novartis Pharmaceuticals
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Kidney Neoplasms

Start date: 2002-04-01
Primary completion: 2003-08-01
Enrollment: 53

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.